ArticleTherapeutics and clinical risk management2018

Identifying a subpopulation with higher likelihoods of early response to treatment in a heterogeneous rare disease: a post hoc study of response to teduglutide for short bowel syndrome.

Kristina S Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.